FDA inspection
Qilu Pharmaceutical Co., Ltd. (Laoling Site): FDA inspection ending Aug 2, 2024
FDA inspection 1249114 · No Action Indicated (NAI) · Dezhou
Key facts
| Inspection ID | 1249114 |
|---|---|
| Firm | Qilu Pharmaceutical Co., Ltd. (Laoling Site) |
| FEI number | 3026771716 |
| Address | Circular Economy Demonstration Park, Laoling County |
| City | Dezhou |
| Fiscal year | 2024 |
| Inspection end date | Aug 2, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data